万邦医药
(301520)
| 流通市值：23.72亿 | | | 总市值：63.26亿 |
| 流通股本：3493.84万 | | | 总股本：9317.14万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 87,757,664.33 | 30,541,322 | 274,180,232.26 | 209,425,876.45 |
| 营业总成本 | 104,892,117.23 | 40,632,188.33 | 265,143,198.25 | 206,411,326.1 |
| 其他经营收益 | | | | |
| 营业利润 | -3,147,479.38 | -1,804,233.84 | 41,465,533.78 | 30,430,233.06 |
| 利润总额 | -3,223,666.84 | -1,804,235.04 | 35,853,138.42 | 30,387,251.72 |
| 净利润 | 137,992.87 | -261,782.16 | 36,434,453.57 | 33,110,619.12 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 0 | 0 |
| 综合收益总额 | 137,992.87 | -261,782.16 | 36,434,453.57 | 33,110,619.12 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,336,895,748.34 | 1,351,060,177.36 | 1,360,152,453.43 | 1,363,170,585.81 |
| 非流动资产: | | | | |
| 非流动资产合计 | 481,829,702.28 | 249,851,407.31 | 242,373,988.79 | 227,987,923.65 |
| 资产总计 | 1,818,725,450.62 | 1,600,911,584.67 | 1,602,526,442.22 | 1,591,158,509.46 |
| 流动负债: | | | | |
| 流动负债合计 | 267,740,872.48 | 65,581,016.41 | 65,438,374.59 | 62,364,528.2 |
| 非流动负债: | | | | |
| 非流动负债合计 | 21,866,081.29 | 19,696,185.4 | 21,691,915 | 16,027,889.3 |
| 负债合计 | 289,606,953.77 | 85,277,201.81 | 87,130,289.59 | 78,392,417.5 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,496,560,326.03 | 1,515,634,382.86 | 1,515,396,152.63 | 1,512,766,091.96 |
| 股东权益合计 | 1,529,118,496.85 | 1,515,634,382.86 | 1,515,396,152.63 | 1,512,766,091.96 |
| 负债和股东权益合计 | 1,818,725,450.62 | 1,600,911,584.67 | 1,602,526,442.22 | 1,591,158,509.46 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 95,291,249.75 | 41,831,962.98 | 252,719,471.35 | 220,962,825.61 |
| 经营活动现金流出小计 | 94,485,482.57 | 46,203,838.48 | 260,642,309.92 | 214,603,429.15 |
| 经营活动产生的现金流量净额 | 805,767.18 | -4,371,875.5 | -7,922,838.57 | 6,359,396.46 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 834,999,180.57 | 354,200,349.82 | 1,632,953,321.66 | 1,245,687,125.2 |
| 投资活动现金流出小计 | 752,956,613.48 | 442,129,455.08 | 1,618,424,730.99 | 1,336,106,543.4 |
| 投资活动产生的现金流量净额 | 82,042,567.09 | -87,929,105.26 | 14,528,590.67 | -90,419,418.2 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | 0 | 0 | 0 |
| 筹资活动现金流出小计 | 18,810,042.93 | 0 | 35,602,457.63 | 34,288,127.13 |
| 筹资活动产生的现金流量净额 | -18,810,042.93 | 0 | -35,602,457.63 | -34,288,127.13 |
| 汇率变动对现金及现金等价物的影响 | -45.48 | 0 | 0 | 0 |
| 现金及现金等价物净增加额 | 64,038,245.86 | -92,300,980.76 | -28,996,705.53 | -118,348,148.87 |
| 期末现金及现金等价物余额 | 214,335,975.9 | 57,996,749.28 | 150,297,730.04 | 60,946,286.7 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 64,038,245.86 | - | -28,996,705.53 | - |